Loading song details...
AGDD 2024 D1S14 Drug Device Combination Products A New Methodology For Evaluation
No description available.
MP3 Download
Video Download
Related Songs
22:47
AGDD 2024 D1S14 Drug Device Combination Products A New Methodology For Evaluation
7:07
AGDD 2024 D2S14 Closing Remarks
16:14
AGDD 2024 D1S02 IVRT Methods For In Situ Depot Forming Long Acting Injectable Products
15:29
AGDD 2024 D1S11 Orally Inhaled Drug Product PSGs Considerations For Using Modeling And Sim
21:06
AGDD 2024 D2S09 Guidance For Industry Content And Format Of Composition Statement
21:24
GDF 2024 D1S14 ANDA Program Statistics
22:53
AGDD 2024 D1S10 Orally Inhaled Drug Product PSGs General Considerations Using The Alternative
22:07
AGDD 2024 D2S06 Emerging Generic Oligonucleotides Challenges And Progress
18:42
AGDD 2024 D1S08 Approaches For Evaluation Of Formulation Differences On Performance Topical
5:24
AGDD 2024 D1S16 Closing Remarks From Day One
12:28
AGDD 2024 D1S15 Approaches To Analyzing Comparative Use Human Factors Studies
11:54
AGDD 2024 D2S05 1 Totality Of Evidence Including Physiologically Based Pharmacokinetic Modeling
22:02
AGDD 2024 D2S11 ICH M13A First Guideline For Bioequivalence
17:29
AGDD 2024 D1S01 Keynote Address
29:19
AGDD 2024 D2S07 The Journey Of First Approvals Complex Generic Long Acting Injectable Products
17:12
AGDD 2024 D1S07 Enhanced Understanding Of Structure Performance Relationship Using Modeling
15:57
AGDD 2024 D1S04 Application Of Adaptive Perfusion As In Vitro Release Testing Method
1:56:58
AGDD 2025 D1S02 Novel Bioequivalence Study Design Recommendations
22:50
AGDD 2024 D2S08 Q A Discussion Panel 2
28:49